ALC 3.92% 5.3¢ alcidion group limited

General Discussion / Social Media, page-2610

  1. 476 Posts.
    lightbulb Created with Sketch. 79
    I've now had time to read the Annual Report thoroughly.

    A few observations.

    A 10% increase in revenue for a company in a growth phase (from a low base) is really not very impressive. Yes - they offered up plenty of reasons/excuses for the modest increase including Brexit, UK federal election, Covid.

    The 'main' focus now seems to be the UK. Yes - It is by far the largest pot of money available across the 3 'districts'; Aust, NZ and the UK in which they have chosen to work.

    The strategy - Capital raising to fund growth (Completed),
    build up of management and sales teams (underway and expected to be largely completed during FY21) to participate in anticipated fast growth in sector. "....with a restructuringand expansion of our sales team, ensuring wenow have the resources required to successfullygrow our market share across the NationalHealth Service (NHS)", "..... In all marketswe now have a Miya Precision customerreference site, as well as a strong pipeline ofopportunities and a greatly enhanced salesteam".

    Acquisitions (ongoing search),
    Growth...…….. (hopeful).

    There is a very upbeat tone to the report (I prefer under promise and over deliver). "......we enter FY2021 confidently, primed forfurther growth, with $29.8M of already sold revenueof which $12.8M is expected to be recognised inFY21, a strong sales pipeline of future businessand our newly rebranded Miya product suite".


    For me they have 12-18 months to deliver on the 'upbeat tone'.
 
watchlist Created with Sketch. Add ALC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.